The Jon Block Group Has Article Published in Medical Devices: Evidence and Research Journal

The Jon Block Group is pleased to announce the recent publication of The Photodynamic Bone Stabilization System: a minimally invasive, percutaneous intramedullary polymeric osteosynthesis for simple and complex long bone fractures, which was included in the recent edition of Medical Devices: Evidence and Research.

The treatment of osteoporotic long bone fractures is difficult due to diminished bone density and compromised biomechanical integrity. The majority of osteoporotic long bone fractures occur in the metaphyseal region, which poses additional problems for surgical repair due to increased intramedullary volume.…

Leave a comment Continue Reading →

The Jon Block Group to Participate in J.P. Morgan Healthcare Conference

jpm_logoWe are pleased to announce that members of the Jon Block Group will be participating in the annual J.P. Morgan Healthcare conference, taking place at the Westin St. Francis Hotel in San Francisco, California from January 12-15, 2015.

The 33rd Annual J.P. Morgan Healthcare Conference is the largest annual investment event in the medical technology industry, featuring approximately 300 companies, both public and private and the opportunity to network with some of the biggest names in the biopharma, device, diagnostic, and healthcare sectors.…

Leave a comment Continue Reading →

Dr. Jon Block is Featured Speaker at DLA Piper Forum

Dr. Jon Block was a featured speaker recently and participated in the following presentation on Monday, November 10th, 2014.

Driving Commercialization Success with an Effective Publication Strategy

Dr. Jon Block
Founder of The Jon Block Group
Dr. Natalie DeWitt
Director of Research Development at Baxter Laboratories at Stanford

DLA_Piper_logoresize

JBG_forum1

DLA Piper
555 Mission Street, Suite 2400
San Francisco, CA 94105

Medical device companies have shifted financing sources from early VC to strategic partnerships, and subsequently exits in the form of acquisitions over IPOs.…

Leave a comment Continue Reading →